Results 161 to 170 of about 254,141 (317)
The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement [PDF]
Jan Mizera +8 more
openalex +1 more source
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT Biallelic pathogenic variants in AKR1D1 cause Δ4‐3‐oxosteroid 5β‐reductase deficiency, disrupt bile acid synthesis, and result in Congenital Bile Acid Synthesis defect type 2 (CBAS2). CBAS2 presents in infancy with cholestasis, coagulopathy, and failure to thrive.
Jade Hudson +3 more
wiley +1 more source
Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy. [PDF]
Front Med (Lausanne)Xu L, Hou C, Jie J, Jia Z, Song L, Li D.
europepmc +1 more source
A Kinase-Independent Activity of Cdk9 Modulates Glucocorticoid Receptor-Mediated Gene Induction [PDF]
, 2014 Rong Zhu +6 more
openalex +1 more source
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Nasal airway obstruction (NAO) is prevalent with substantial health and quality of life burdens. Nasal valve collapse (NVC) is one structural cause of NAO. Temperature‐controlled radiofrequency (TCRF) nasal valve remodeling offers an alternative to invasive surgery.
David W. Kennedy +7 more
wiley +1 more source
Impact of glucocorticoid administration on therapeutic outcomes of immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis. [PDF]
Front Med (Lausanne)Zhang S, Chen SD, Chen L, Hong B.
europepmc +1 more source
Essential role of caldesmon in the actin filament reorganization induced by glucocorticoids. [PDF]
, 1995 Flora Castellino +3 more
openalex +1 more source